Ultragenyx Pharmaceuticals RARE announced that the FDA has granted the Breakthrough Therapy designation to its ...

In a conversation with People magazine in 2024, Colin Farrell opened up for the first time about his son's rare condition: ...

Angelman Syndrome Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted Angelman syndrome epidemiology in the 7MM, i.e., the United ...

Angelman syndrome is a rare genetic disorder that mainly affects the nervous system and causes developmental delays, speech difficulties, and movement problems. The condition has recently gained ...

Angelman syndrome affects about 1 in 12,000 to 20,000 people. It's a lifelong condition that typically results in severe developmental delays, balance and movement issues, and little to no verbal ...

James was diagnosed with Angelman syndrome when he was just 2 1/2 years old.Farrell and Bordenave, 53, filed for a conservatorship of their son in 2021 before his 18th birthday.